Alzheimer's Drugs Market Is Estimated To Witness High Growth Owing To Rising Alzheimer's Disease Prevalence
Alzheimer's drugs aim to slow or stop the progression of Alzheimer's disease. The drugs help reduce memory loss and improve quality of life for people living with mild to moderate Alzheimer's disease through effects on neurotransmitters affected by Alzheimer's. The global Alzheimer's drugs market is estimated to be valued at US$ 4.86 Bn in 2023 and is expected to exhibit a CAGR of 11%...
0 Comments
0 Shares
375 Views